Development and Evaluation of Adeno-HTLV-III Hybrid Virus and Non-Cytopathic HTLV-III Mutant for Vaccine Use

h "
"'

Fig. 13

In situ hybridization of CV-l cells infected
with, putative recombinant RIV gpl2O/Adenovirus' 2. In situ hybridization was performed
on vir'as-infected uonolayers of, CV-l cells
using DNB-labeled pAD.HMLPgpl2O as probe as
described in the text. Virus i so.a tos were
derived!ru 293 cells transfected or infected with wt Ad 2 + pAD. ENV. NDI and 'with Ad2
+ pAD. ENV. NDI. Cells in the lover right
are non-infected CV-l control cells.

33